• no-js

About MORU

The Mahidol Oxford Tropical Medicine Research Unit (MORU) develops effective and practical means of diagnosing and treating malaria and other neglected diseases such as melioidosis, typhus, TB and leptospirosis.

MORU was established in 1979 as a research collaboration between Mahidol University (Thailand), Oxford University (UK) and the UK’s Wellcome Trust.

MORU’s main office and laboratories are located within the Faculty of Tropical Medicine at Mahidol University in Bangkok, Thailand, with MORU study sites and collaborations across Thailand, Asia and Africa.

MORU is generously supported with significant funding from the Wellcome Trust, our major funding partner. We also receive funding from other trusts and foundations, governments, and multi-lateral donors.

Read more about MORU

Recent Publications

Efficacy, safety and pharmacokinetics of KAF156 in adult patients with acute, uncomplicated P. falciparum or vivax malaria: a proof-of-concept, open label study TROPICAL MEDICINE & INTERNATIONAL HEALTH , 20

Patterns of Flavivirus Seroprevalence in the Human Population of Northern Laos. Am J Trop Med Hyg , 93 (5)
View article

Profiling the host response to malaria vaccination and malaria challenge. Vaccine , 33 (40)
View article

See all recent publications